NASDAQ:WINT

Windtree Therapeutics Stock Insider Trading

etoro logo Buy WINT
*Your capital is at risk
$0.0140
+0.0004 (+2.94%)
At Close: Jun 03, 2026

Windtree Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 9.39M and sold 4.45M WINT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 9.39M shares
Sell 4.45M shares
82% Buy Activity
Weak Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Aug 03, 2025
Buy
Common Stock
J-Other
Kucharchuk Andrew Albert
Director 0
Value: $0
Aug 03, 2025
Buy
Common Stock
J-Other
Kucharchuk Andrew Albert
Director 0
Value: $0
Jan 08, 2025
Buy
Common Stock
J-Other
Kelly Leanne
Director 0
Value: $0
Jan 08, 2025
Buy
Common Stock
J-Other
Kelly Leanne
Director 0
Value: $0
Oct 08, 2024
Buy
Common Stock
P-Purchase
Fraser Craig
President And CEO
CEO / President 5 431
Value: $5K
Oct 08, 2024
Buy
Common Stock
P-Purchase
Fraser Craig
President And CEO
CEO / President 5 431
Value: $5K
Aug 13, 2024
Buy
Common Stock
J-Other
Pelletier Saundra L
Director 0
Value: $0
Aug 13, 2024
Buy
Common Stock
J-Other
Latkin Jed
Director 0
Value: $0
Aug 13, 2024
Buy
Common Stock
J-Other
Latkin Jed
Director 0
Value: $0
Aug 13, 2024
Buy
Common Stock
J-Other
Pelletier Saundra L
Director 0
Value: $0
Jul 22, 2024
Buy
Warrants (Right to Buy)
A-Award
Simonson Steven
SVP, Chief Medical Officer
Officer 2 674
Value: $11.0K
Jul 22, 2024
Buy
Series C Preferred Stock
A-Award
Simonson Steven
SVP, Chief Medical Officer
Officer 13
Value: $2K
Jul 22, 2024
Buy
Warrants (Right to Buy)
A-Award
Fraser Craig
President And CEO
CEO / President 4 011
Value: $16.5K
Jul 22, 2024
Buy
Series C Preferred Stock
A-Award
Fraser Craig
President And CEO
CEO / President 19
Value: $3K
Jul 22, 2024
Buy
Series C Preferred Stock
A-Award
Fraser Craig
President And CEO
CEO / President 19
Value: $3K
Jul 22, 2024
Buy
Warrants (Right to Buy)
A-Award
Fraser Craig
President And CEO
CEO / President 4 011
Value: $16.5K
Jul 22, 2024
Buy
Series C Preferred Stock
A-Award
Simonson Steven
SVP, Chief Medical Officer
Officer 13
Value: $2K
Jul 22, 2024
Buy
Warrants (Right to Buy)
A-Award
Simonson Steven
SVP, Chief Medical Officer
Officer 2 674
Value: $11.0K
Sep 27, 2023
Buy
Common Stock
P-Purchase
Fraser Craig
President And CEO
CEO / President 2 500
Value: $3K
Sep 27, 2023
Buy
Common Stock
P-Purchase
Fraser Craig
President And CEO
CEO / President 2 500
Value: $3K
Sep 26, 2023
Buy
Common Stock
P-Purchase
Fraser Craig
President And CEO
CEO / President 2 500
Value: $2K
Sep 26, 2023
Buy
Common Stock
P-Purchase
Fraser Craig
President And CEO
CEO / President 2 500
Value: $2K
Aug 24, 2023
Buy
Common Stock
Mcandrew Jamie
Vp, Controller, & Cao
Officer 0
Value: $0
Aug 24, 2023
Buy
Common Stock
Mcandrew Jamie
Vp, Controller, & Cao
Officer 0
Value: $0
Aug 24, 2023
Buy
Employee Stock Option (Right to Buy)
Mcandrew Jamie
Vp, Controller, & Cao
Officer 200
Value: $118.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT WINDTREE THERAPEUTICS INC
Windtree Therapeutics
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE